<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR19">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhou</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Jang</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Fleischmann</surname>
    <given-names>RM</given-names>
   </name>
   <name>
    <surname>Bouman-Thio</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Marini</surname>
    <given-names>JC</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis</article-title>
  <source>J Clin Pharmacol</source>
  <year>2007</year>
  <volume>47</volume>
  <fpage>383</fpage>
  <lpage>396</lpage>
  <pub-id pub-id-type="doi">10.1177/0091270006298188</pub-id>
  <?supplied-pmid 17322150?>
  <pub-id pub-id-type="pmid">17322150</pub-id>
 </element-citation>
</ref>
